Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy
about
CIViC databaseThe Janus Face of Death Receptor Signaling during Tumor ImmunoeditingTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cellsc-FLIP, a master anti-apoptotic regulatorNovel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP proteinHydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module.c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrineEnzalutamide: an evidence-based review of its use in the treatment of prostate cancerMetastatic castration-resistant prostate cancer: critical review of enzalutamide.Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.Efficient drug delivery and induction of apoptosis in colorectal tumors using a death receptor 5-targeted nanomedicine.Identification and Characterization of the Interaction Site between cFLIPL and CalmodulinCrosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancerThe direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific.Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells.How do tumor cells respond to HDAC inhibition?PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.Doxycycline synergizes with doxorubicin to inhibit the proliferation of castration-resistant prostate cancer cells.Combination of Nexrutine and docetaxel suppresses NFκB-mediated activation of c-FLIP.Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists
P2860
Q27612411-E7166E6C-5744-4CD0-A012-19750420CA15Q28070036-D30E8578-15FA-44DC-87E8-DD70F717F4C4Q28391040-832D8733-4B35-4706-BF3D-272460D2846FQ28391119-5CF62D0F-A82E-4F66-9622-D3A35FEB4402Q28397635-EC9B0310-999F-4364-9567-F8C5E34CA4CFQ33947136-E360B959-DF45-44E3-B507-E2804B41797EQ34225131-A94F788D-3539-43F9-B362-BB4953624E5EQ34339501-007FB7DB-BA63-410A-93C0-2963F3705FF5Q34381852-2517D4BC-DA49-4772-96A9-8BAEBA665CB1Q34449938-3FC6288E-4E4E-4CAA-A3AE-DC015C5957C3Q35600313-FA7FD9CF-5C7C-4CC4-8ACF-1C37CF8240FBQ35830561-C9CF5666-C277-4DA8-95A4-1135CA313093Q37046523-3EB5D8DD-B8C7-4876-AE18-4949961E7BCBQ37711593-301FE7BB-CFDF-4091-92D6-D846C2615F90Q38812632-21468387-1CCA-4A5B-8C67-F632FE753971Q38817005-C6A525A8-BE37-40D9-9BE9-5A96F81EA781Q42487948-6D412FD7-5D7A-4A10-8DB4-CD494B41BA93Q47687132-3E5F32D2-A546-4459-9EE0-55058A729980Q48171505-3B528180-F5C7-4A2B-B4C7-6C5AFA485F7FQ50070105-64E866E3-17F5-40FD-9BAA-89579667D1E8Q57801734-FFEF9A29-89C6-4D6D-898D-0B768D4C61AC
P2860
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Elevation of c-FLIP in castrat ...... ogen receptor-targeted therapy
@ast
Elevation of c-FLIP in castrat ...... ogen receptor-targeted therapy
@en
Elevation of c-FLIP in castrat ...... gen receptor-targeted therapy.
@nl
type
label
Elevation of c-FLIP in castrat ...... ogen receptor-targeted therapy
@ast
Elevation of c-FLIP in castrat ...... ogen receptor-targeted therapy
@en
Elevation of c-FLIP in castrat ...... gen receptor-targeted therapy.
@nl
altLabel
Elevation of c-FLIP in Castrat ...... ogen Receptor-Targeted Therapy
@en
prefLabel
Elevation of c-FLIP in castrat ...... ogen receptor-targeted therapy
@ast
Elevation of c-FLIP in castrat ...... ogen receptor-targeted therapy
@en
Elevation of c-FLIP in castrat ...... gen receptor-targeted therapy.
@nl
P2093
P2860
P3181
P1476
Elevation of c-FLIP in castrat ...... ogen receptor-targeted therapy
@en
P2093
Clare McCourt
Daniel B Longley
David J J Waugh
Joe M O'Sullivan
Manuel Salto-Tellez
Marina Scarpelli
Pamela Maxwell
Roberta Mazzucchelli
P2860
P304
P3181
P356
10.1158/1078-0432.CCR-11-3277
P407
P577
2012-07-15T00:00:00Z